Advisors Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
Advisors Asset Management's NVAX Position: Q2 2024 in Review
Advisors Asset Management sold out of Novavax (NVAX) in Q2 2024, closing a stake of 1,479 shares — an estimated $7.07K sold.
Advisors Asset Management first reported a position in NVAX in Q2 2020 and held it in 16 quarters. The position peaked at $4.66M in Q2 2021. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.
- Advisors Asset Management reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
- Advisors Asset Management sold 1,479 Novavax shares in Q2 2024, an estimated $7.07K.
- Advisors Asset Management first reported a position in Novavax in Q2 2020 and held it in 16 quarters.
- Advisors Asset Management's Novavax position peaked at $4.66M in Q2 2021.
- 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.
Based on Advisors Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.